行情

TRPX

TRPX

Therapix Bio
NASDAQ

实时行情|Nasdaq Last Sale

1.319
-0.011
-0.80%
已收盘, 16:00 12/13 EST
开盘
1.330
昨收
1.330
最高
1.380
最低
1.252
成交量
3.78万
成交额
--
52周最高
5.15
52周最低
1.180
市值
461.41万
市盈率(TTM)
-0.5544
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

TRPX 新闻

  • 沪指高开高走 美财长称未将美元武器化
  • 新浪财经.2小时前
  • 挪威电信称华为仍将参与挪威5G建设
  • 新浪财经综合.6小时前
  • 苹果特斯拉等遭集体诉讼 因供应商非法雇佣童工
  • 新浪科技.6小时前
  • 新西兰证券交易所因连接问题暂停所有交易
  • 新浪财经.7小时前

更多

所属板块

制药
-0.74%
制药与医学研究
-0.32%

热门股票

名称
价格
涨跌幅

TRPX 简况

Therapix Biosciences Ltd, formerly Nasvax Ltd, is an Israel-based company active in the pharmaceutical sector. The Company develops improved vaccines and immunotherapeutics. Its products include Anti-CD3 oral immunotherapy, directed toward the treatment of inflammatory and autoimmune diseases; Group-common Pneumococcal Vaccine, based on surface proteins that are highly conserved among pneumococcal strains, hence able to stimulate protective immune responses against pneumococcal strains in general; Alzheimer’s Disease Immunotherapy develops immunotherapeutic products for Alzheimer’s disease; and Adjuvant-Delivery platform, VaxiSome, serves both as a potent adjuvant for stimulating enhanced immune responses via the Th1 and Th2 pathways as well as an efficient delivery system. This liposomal adjuvant delivery system also may be applied to augment the bioactivity of other established adjuvants and cytokines.
展开

Webull提供Therapix Biosciences Ltd - ADR的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。